INBP insider filings
INTEGRATED BIOPHARMA INC — 46 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-25. Screen INBP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for INBP between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — INTEGRATED BIOPHARMA INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Milmoe William H. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | DeSantis Damon — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Friedman Eric J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4/A | Friedman Eric J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Milmoe William H. — Director | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4 | DeSantis Damon — Director, 10% owner | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4 | DESANTIS CARL — 10% owner | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-04-17 | 4/A | Milmoe William H. — Director | Gift (G): 8,966,547 @ $0 · Gift (G): 2,235,417 @ $0 | EDGAR |
| 2026-03-26 | 4 | DESANTIS CARL — 10% owner | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2026-03-25 | 4 | Milmoe William H. — Director, 10% owner | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2026-03-25 | 4 | DeSantis Damon — Director | Gift (G): 1,356,293 @ $0 · Gift (G): 7,392 @ $0 | EDGAR |
| 2025-12-10 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, 10% owner | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | DeSantis Damon — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | FRIEDMAN ERIC J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 @ $0.09 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 144,445 @ $0.09 · Disposition to issuer (D): 144,445 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 144,445 @ $0.09 · Disposition to issuer (D): 144,445 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 135,000 @ $0.09 · Disposition to issuer (D): 135,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Canarick Robert — Director | Grant/award (A): 175,000 @ $0.09 · Disposition to issuer (D): 175,000 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 55,555 @ $0.09 · Disposition to issuer (D): 55,555 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 65,000 @ $0.09 · Disposition to issuer (D): 65,000 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 55,555 @ $0.09 · Disposition to issuer (D): 55,555 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | DeSantis Damon — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | FRIEDMAN ERIC J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-11-29 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2023-11-29 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2023-11-29 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | Masi Dina — Chief Financial Officer | Grant/award (A): 50,000 @ $0.09 · Disposition to issuer (D): 50,000 (derivative) @ $0.09 | EDGAR |
| 2023-09-21 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 3,410,512 @ $0.40 · Grant/award (A): 50,000 @ $0.09 · Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 66,667 (derivative) @ $0 · Grant/award (A): 21,667 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 3,410,512 @ $0.40 · Grant/award (A): 50,000 @ $0.09 · Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 66,667 (derivative) @ $0 · Grant/award (A): 21,667 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2023-07-20 | 4 | Milmoe William H. — Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | Canarick Robert — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | FRIEDMAN ERIC J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | DeSantis Damon — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | KAY CHRISTINA — Co-Chief Executive Officer, Director | Gift (G): 50,000 @ $0.34 | EDGAR |
| 2023-06-01 | 4 | RIVA SHEPPARD — Co-Chief Executive Officer, Director | Gift (G): 50,000 @ $0.34 | EDGAR |
Recent 8-K events — INTEGRATED BIOPHARMA INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INBP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →